Search - tctmd.com

Displaying 81 - 100 of 157

Sort: Relevancy | Date

Presentation TCT 2014

Cobalt-Chromium Sirolimus-Eluting Platforms IV: Firehawk

Presenter: Alexandre Abizaid, Pieter C. Smits, Robert J. Gil, Bo Xu

September 15, 2014

Presentation TCT 2014

Cobalt-Chromium Sirolimus-Eluting Platforms III: Inspiron

Presenter: Alexandre Abizaid, Pieter C. Smits, Robert J. Gil, Pedro A. Lemos

September 15, 2014

Presentation TCT 2014

Cobalt-Chromium Sirolimus-Eluting Platforms II: ORSIRO

Presenter: Alexandre Abizaid, Pieter C. Smits, Robert J. Gil, Stephan Windecker

September 15, 2014

Presentation TCT 2014

Cobalt-Chromium Sirolimus-Eluting Platforms I: BioMime

Presenter: Alexandre Abizaid, Pieter C. Smits, Robert J. Gil, Ricardo A. Costa

September 15, 2014

News Conference News TCT 2014

Novel Biodegradable Polymer DES Shows Efficacy, Long-term Safety

September 15, 2014

News Conference News TCT 2014

EES Decrease Restenosis, TVR vs. BMS in Non-STEMI

September 15, 2014

News Conference News TCT 2014

COMPARE II: BES, EES Show Similar Outcomes at Three Years

September 13, 2014

News Conference News ESC 2014

BIOSCIENCE: Biodegradable Polymer SES Noninferior to Durable Polymer EES in All-Comers Trial

Yael L. Maxwell

September 01, 2014

News Daily News

HOST-ASSURE: Promus Element Noninferior to Resolute in All-Comers Population

July 10, 2014

News Industry News

Svelte Medical Systems Announces Completion of 6-Month Follow-up in the DIRECT II Drug-Eluting Stent Study

May 29, 2014

News Industry News

NATEC Medical Ltd Receives CE Mark Approval for the Coral CoCr Coronary Stent System

May 16, 2014

News Industry News

Micell Technologies Announces Clinical Data from MiStent SES Studies Will Be Presented at EuroPCR 2014

May 15, 2014

News Industry News

Tryton Medical Announces Events at EuroPCR 2014 in Paris

May 12, 2014

News Industry News

InspireMD Announces Positive Results from iMOS Prime Registry for the MGuard Prime EPS

May 07, 2014

News Industry News

Boston Scientific Announces Schedule for Presentations at American College of Cardiology 2014

March 27, 2014

News Industry News

CeloNova’s Coronary Stent System Could Mean Faster Healing of Arteries and Greatly Reduced Use of Blood-thinning Medication

March 18, 2014

News Daily News

DUTCH PEERS Published: Third-Generation Zotarolimus, Everolimus Stents Equivalent

February 12, 2014

News Daily News

Second-Generation DES the Better Choice for STEMI Patients

December 09, 2013

News Industry News

Boston Scientific Receives FDA Approval For Promus Premier™ Everolimus-Eluting Platinum Chromium Coronary Stent System

November 24, 2013

News Conference News TCT 2013

Meta-analysis: Most DES Safer Than BMS, Biodegradability Offers No Extra Benefit

November 03, 2013

Advertisement

Cobalt-Chromium Sirolimus-Eluting Platforms IV: Firehawk

Cobalt-Chromium Sirolimus-Eluting Platforms III: Inspiron

Cobalt-Chromium Sirolimus-Eluting Platforms II: ORSIRO

Cobalt-Chromium Sirolimus-Eluting Platforms I: BioMime

Novel Biodegradable Polymer DES Shows Efficacy, Long-term Safety

EES Decrease Restenosis, TVR vs. BMS in Non-STEMI

COMPARE II: BES, EES Show Similar Outcomes at Three Years

BIOSCIENCE: Biodegradable Polymer SES Noninferior to Durable Polymer EES in All-Comers Trial

HOST-ASSURE: Promus Element Noninferior to Resolute in All-Comers Population

Svelte Medical Systems Announces Completion of 6-Month Follow-up in the DIRECT II Drug-Eluting Stent Study

NATEC Medical Ltd Receives CE Mark Approval for the Coral CoCr Coronary Stent System

Micell Technologies Announces Clinical Data from MiStent SES Studies Will Be Presented at EuroPCR 2014

Tryton Medical Announces Events at EuroPCR 2014 in Paris

InspireMD Announces Positive Results from iMOS Prime Registry for the MGuard Prime EPS

Boston Scientific Announces Schedule for Presentations at American College of Cardiology 2014

CeloNova’s Coronary Stent System Could Mean Faster Healing of Arteries and Greatly Reduced Use of Blood-thinning Medication

DUTCH PEERS Published: Third-Generation Zotarolimus, Everolimus Stents Equivalent

Second-Generation DES the Better Choice for STEMI Patients

Boston Scientific Receives FDA Approval For Promus Premier™ Everolimus-Eluting Platinum Chromium Coronary Stent System

Meta-analysis: Most DES Safer Than BMS, Biodegradability Offers No Extra Benefit

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content